Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer - Wikidata - wikimedia - TriplyDB

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

http://www.wikidata.org/entity/Q28364208

about

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.Response prediction to neoadjuvant chemotherapy: comparison between pre-therapeutic gene expression profiles and in vitro chemosensitivity assay Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer.The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.Can ki-67 play a role in prediction of breast cancer patients' response to neoadjuvant chemotherapy?Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review Ki-67 biomarker in breast cancer of Indian women Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer.The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer.Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium Cancer network activity associated with therapeutic response and synergism.Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study.Treatment response to preoperative anthracycline-based chemotherapy in locally advanced breast cancer: the relevance of proliferation and apoptosis rates.Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy.High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis.Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer.Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy".Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer.Correlation between ER, PR, HER-2, Bcl-2, p53, proliferative and apoptotic indexes with HER-2 gene amplification and TOP2A gene amplification and deletion in four molecular subtypes of breast cancer.Outcome prediction of pulmonary metastasectomy can be evaluated using metastatic lesion in osteosarcoma patients.Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer.The levels of Ki-67 positive are positively associated with lymph node metastasis in invasive ductal breast cancer.Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.[Assessment of proliferation: core biopsy or resection specimen? Discrepancies in breast cancer with low and high proliferation].Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.Developments in Ki67 and other biomarkers for treatment decision making in breast cancer.Practical consensus recommendations regarding the management of hormone receptor positive early breast cancer in elderly women.

P2860

Q33903965-D8430ACB-EC85-489E-8416-477D792F8405 Q34795754-47687731-A5BB-407F-903E-EE267B317531 Q35012858-BF7B2BA2-BF9C-4F1D-89FF-5CCCAD82C045 Q35029578-BBB40EF2-3A45-43B1-89A2-962CB8938278 Q35160045-5A5ECA7F-E916-4DF0-92A3-AC57C75FF452 Q35904441-66ADABBB-DA0D-46F1-9479-594F6F53F509 Q35913434-72B3BEE3-2043-4E73-9918-29530107C0D1 Q36175746-3F593268-CDCC-4C69-9BE7-D63D39CC5FF9 Q36393082-24EC237B-99C9-4914-A18E-A7DE8EDA6041 Q36648420-D00A4662-9CF2-4CAD-A75B-A682CF4987CF Q36653693-FB033EDF-7A84-4B5F-B84D-513AFF2BA8C5 Q36696517-31BD95C5-A1CD-4A73-B163-679FDA5A0E15 Q36892788-7BFBEFF4-F29D-453E-97B0-2B42EB43AFC4 Q37121271-3EABC3BA-BC64-4B20-A502-627E9AE3EAA0 Q37199267-F464F89A-84B3-4E2E-B5DE-AF71D2A1739A Q38395457-CAFB35EE-49FA-41B7-A90E-4D7D4C0B8E20 Q38397572-A5524E64-49F5-43B3-8D38-3D4C2C254C3E Q38397819-41EA0560-44BB-4FB1-9E06-0866AF6FC77B Q38414170-EFEC18B9-FE60-42EF-B6A7-32B7F0C4B65E Q38770344-4CC17F68-AA53-4B3C-AEC5-FB42CA035FA9 Q40362934-41A83E2E-299E-4723-92B2-1E0A9F8D1FE4 Q42453200-89698198-A130-4B11-9197-17ECDC77E690 Q43430523-33E7F6F8-7F4E-4839-8F09-121887830D6C Q44053869-F3A64ED7-F059-4445-995D-0B7AD6C6EFF6 Q44510543-F40F4A1D-FB30-4AD8-8F08-0BF24BF24CEF Q44966169-4D7A0096-BB79-472D-BD91-116744BA7C0A Q46324717-8BCEC179-D06C-4470-8E2A-CF01883055B1 Q46784173-48322BB2-E345-4745-B284-F605517EB3AB Q53099478-C611C5DC-7025-4453-8061-BF3D2A53C978 Q53674063-64EAC0A4-B6E8-4281-9CFF-FE4B2428764E Q54481769-C4B6FD9D-423D-4BB3-9EB8-C3B3B2AB0A7F Q55208842-153DB0AE-9E28-4105-A6B3-85F567797E60

P2860

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

http://www.wikidata.org/entity/Q28364208

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Relationship between tumour sh ...... therapy in human breast cancer

@ast

Relationship between tumour sh ...... therapy in human breast cancer

@en

Relationship between tumour sh ...... therapy in human breast cancer

@nl

type

label

Relationship between tumour sh ...... therapy in human breast cancer

@ast

Relationship between tumour sh ...... therapy in human breast cancer

@en

Relationship between tumour sh ...... therapy in human breast cancer

@nl

prefLabel

Relationship between tumour sh ...... therapy in human breast cancer

@ast

Relationship between tumour sh ...... therapy in human breast cancer

@en

Relationship between tumour sh ...... therapy in human breast cancer

@nl

P1433

Q28364208-34991ED0-6C90-491E-83BC-292580F0E0A7

P1476

Q28364208-D53738CF-B4ED-449B-93FF-4CE525680ED7

P2093

Q28364208-0967D45C-0E1A-40B2-B0EA-A4D0E16935EE

Q28364208-0B57317A-2E33-4708-992F-945E56341A52

Q28364208-2E3D01A9-47C6-4CB8-8389-C06146B6F7E8

Q28364208-39CFC42E-F0C1-459A-9934-36368D8B0741

Q28364208-7B795A75-98F4-48C6-A2BB-4F4F3561A450

Q28364208-8EC38974-DADB-472B-B791-26B4AFE9C1C8

Q28364208-9127D98F-B39B-4264-B452-A81B6B5C5314

Q28364208-99DA2B1C-C97D-4804-8A32-AB4B48AE87A1

Q28364208-9C0A9109-A5B3-4AFD-B64E-75CCD410A350

Q28364208-C07D86B9-C364-4BC1-9A6E-F2A76E3C6371

P2860

Q28364208-56FAA1FE-E3B7-4BBF-A2FF-CEC4EFAB01CF

Q28364208-7890BBDC-83F1-4B15-83BF-CB067A0416F6

Q28364208-92725AA7-0E70-4D46-8125-E77325F7B538

Q28364208-C2840A11-7063-4CAA-AAE0-65C6CEBD8C93

Q28364208-C37665D0-0193-444C-BCEC-8992628C7823

Q28364208-FC8762F0-D2AB-4387-8F92-C114C67BD4C4

P2888

Q28364208-E07F301C-1E15-4C8F-A21F-62461DA02311

P304

Q28364208-310C7B52-E37E-4085-BDC5-D4DC5C133DC1

P31

Q28364208-CE9445B0-E72A-4E6E-BD70-2F5B5787B598

P3181

Q28364208-09F78C87-5408-4A90-9E27-A4F225A11706

P356

Q28364208-C44C77CE-309A-462A-8560-6488B981B7B0

P407

Q28364208-F7DA903C-1E90-475D-8B3C-23776DFF1FAD

P433

Q28364208-828FD6F8-A8F9-4322-A616-0806DB821225

P478

Q28364208-EA3AF425-B3A7-4BC6-B05D-F90FF2A0275E

P50

Q28364208-3D035628-AE7F-49C9-BE6F-6B7A6026E852

P577

Q28364208-13B4A41A-7A3D-4C23-BFC5-CD685E20E2D3

P5875

Q28364208-950DFCCE-B999-4351-9BA6-110763A2D7E7

P6179

Q28364208-9BA21974-3F7C-4F9D-BBB5-A2B08467F911

P698

Q28364208-09140E0F-AFE3-487F-8D7F-CD25CD17C42D

P921

Q28364208-E31D11C6-8D85-4705-B4FA-7C7DC7DCF27A

P932

Q28364208-077D23E4-E520-411F-9775-378DDD20C9B0

P3181

P356

P1433

British Journal of Cancer

P1476

Relationship between tumour sh ...... therapy in human breast cancer

@en

P2093

Aguggini S

http://www.w3.org/2001/XMLSchema#string

Allevi G

http://www.w3.org/2001/XMLSchema#string

Alquati P

http://www.w3.org/2001/XMLSchema#string

Berruti A

http://www.w3.org/2001/XMLSchema#string

Bersiga A

http://www.w3.org/2001/XMLSchema#string

Bertoli G

http://www.w3.org/2001/XMLSchema#string

Betri E

http://www.w3.org/2001/XMLSchema#string

Bolsi G

http://www.w3.org/2001/XMLSchema#string

Bottini A

http://www.w3.org/2001/XMLSchema#string

Brizzi MP

http://www.w3.org/2001/XMLSchema#string

P2860

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.

HER-2/neu as a predictive marker of response to breast cancer therapy.

The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2.

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre.

P2888

P304

1106-1112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2442677

http://www.w3.org/2001/XMLSchema#string

P356

10.1054/BJOC.2001.2048

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11644027

http://www.w3.org/2001/XMLSchema#string

P6179

1030641933

http://www.w3.org/2001/XMLSchema#string

P698

11710821

http://www.w3.org/2001/XMLSchema#string

P921

P932

2375158

http://www.w3.org/2001/XMLSchema#string